Annual report pursuant to section 13 and 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Condensed Consolidated Statements Of Operations    
Product revenue $ 3,023,503 $ 1,118,118
License revenue 44,074 0
Total Revenues 3,067,577 1,118,118
OPERATING EXPENSES    
Cost of product revenue 2,023,441 669,056
Research and development 9,303,077 3,469,078
Plasma center 2,418,156 1,746,864
General and administrative expenses 4,365,334 3,142,289
TOTAL OPERATING EXPENSES 18,110,008 9,027,287
LOSS FROM OPERATIONS (15,042,431) (7,909,169)
OTHER INCOME (EXPENSE):    
Interest income 7,623 20,924
Interest expense (618,225) (30,683)
Change in fair value of stock warrants 43,290 0
Other income 82,497 0
TOTAL OTHER INCOME (EXPENSE) (484,815) (9,759)
LOSS BEFORE INCOME TAXES (15,527,246) (7,918,928)
State income tax benefit 0 617,615
NET LOSS $ (15,527,246) $ (7,301,313)
NET LOSS PER COMMON SHARE - BASIC AND DILUTED $ (2.38) $ (1.39)
WEIGHTED AVERAGE SHARES OUTSTANDING, Basic and Diluted 6,531,029 5,265,771